News Releases


Apr 25, 2003

Insmed Incorporated To Webcast First Quarter Earnings Conference Call; Friday, May 2, at 11:00 a.m. ET - 10:00 a.m. CT

Apr 11, 2003

Insmed Announces Publication of Investment Profile; Full Text Available on Corporate Website

Apr 8, 2003

Insmed Initiates Named Patient Programme For rhIGF-I/rhIGFBP-3, An Investigational Drug for Severe Growth Disorders

Apr 8, 2003

Insmed Chairman to Provide Positive Outlook During's Virtual Healthcare Conference

Apr 7, 2003

Insmed Announces Improved Performance Expectations for First Quarter; Lead Product Candidate Prepared to Enter Phase III Trials

Apr 4, 2003

Insmed Reports Positive Data with rhIGFBP-3 in Cancer; rhIGFBP-3 Improves Effect of Standard Cancer Therapies; rhIGFBP-3 Inhibits Tumor Growth up to 70%

Apr 2, 2003

Insmed CEO to Highlight Near Term Commercial Opportunity; Lead Drug on Track for Potential FDA Approval in 2004; Cash Expected to Fund Operations Through Potential Approval

Apr 1, 2003

Insmed Chairman And CEO Provides Positive Outlook in Special Letter to Shareholders

Mar 28, 2003

Insmed Incorporated Retains Investor Relations International As Investor Relations Counsel; Company to Immediately Implement New Shareholder Communications Program

Feb 3, 2003

Insmed Incorporated Reports Year-End and Fourth Quarter Financial Results